Retrosynthetic design of heterologous pathways.

Tools from metabolic engineering and synthetic biology are synergistically used in order to develop high-performance cell factories. However, the number of successful applications has been limited due to the complexity of exploring efficiently the metabolic space for the discovery of candidate heterologous pathways. To address this challenge, retrosynthetic biology provides an integrated framework to formalize and rationalize the problem of importing biosynthetic pathways into a chassis organism using methods at the interface from bottom-up and top-down strategies. Here, we describe step by step the process of implementing a retrosynthetic framework for the design of heterologous biosynthetic pathways in a chassis organism. The method consists of the following steps: choosing the chassis and the target, selection of an in silico model for the chassis, definition of the metabolic space, pathway enumeration, gene selection, estimation of yields, toxicity prediction of pathway metabolites, definition of an objective function to select the best pathway candidates, and pathway implementation and verification.

[1]  Pablo Carbonell,et al.  A retrosynthetic biology approach to metabolic pathway design for therapeutic production , 2011, BMC Systems Biology.

[2]  Zachary L. Fowler,et al.  High-Yield Resveratrol Production in Engineered Escherichia coli , 2011, Applied and Environmental Microbiology.

[3]  Liu Xianming,et al.  A Time Petri Net Extended with Price Information , 2007 .

[4]  Andrew D Ellington,et al.  Gene synthesis: methods and applications. , 2011, Methods in enzymology.

[5]  Tropsha Alexander,et al.  Predictive quantitative structure-activity relationships modeling: Development and validation of QSAR models , 2010 .

[6]  Pablo Carbonell,et al.  A retrosynthetic biology approach to therapeutics: from conception to delivery. , 2012, Current opinion in biotechnology.

[7]  G. Stephanopoulos,et al.  Optimization of a heterologous pathway for the production of flavonoids from glucose. , 2011, Metabolic engineering.

[8]  Alan Villalobos,et al.  Designing genes for successful protein expression. , 2011, Methods in enzymology.

[9]  Leemor Joshua-Tor,et al.  Strategies for protein coexpression in Escherichia coli , 2006, Nature Methods.

[10]  Adam M. Feist,et al.  Reconstruction of biochemical networks in microorganisms , 2009, Nature Reviews Microbiology.

[11]  George Georgiou,et al.  Strain engineering for improved expression of recombinant proteins in bacteria , 2011, Microbial cell factories.

[12]  Sunwon Park,et al.  Prediction of novel synthetic pathways for the production of desired chemicals , 2010, BMC Systems Biology.

[13]  Jay D Keasling,et al.  Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. , 2007, Metabolic engineering.

[14]  Christopher D Reeves,et al.  Combinatorial biosynthesis for drug development. , 2007, Current opinion in microbiology.

[15]  Hal S Alper,et al.  Using flux balance analysis to guide microbial metabolic engineering. , 2012, Methods in molecular biology.

[16]  O. Yu,et al.  Potential for metabolic engineering of resveratrol biosynthesis. , 2008, Trends in biotechnology.

[17]  Konrad Büssow,et al.  Vectors for co-expression of an unrestricted number of proteins , 2007, Nucleic acids research.

[18]  Jens Nielsen,et al.  Evolutionary programming as a platform for in silico metabolic engineering , 2005, BMC Bioinformatics.

[19]  Bernhard O. Palsson,et al.  BiGG: a Biochemical Genetic and Genomic knowledgebase of large scale metabolic reconstructions , 2010, BMC Bioinformatics.

[20]  Ronan M. T. Fleming,et al.  Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 , 2007, Nature Protocols.

[21]  Pablo Carbonell,et al.  Compound toxicity screening and structure-activity relationship modeling in Escherichia coli. , 2012, Biotechnology and bioengineering.

[22]  Antje Chang,et al.  BRENDA, AMENDA and FRENDA the enzyme information system: new content and tools in 2009 , 2008, Nucleic Acids Res..

[23]  Melanie I. Stefan,et al.  BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models , 2010, BMC Systems Biology.

[24]  Mudita Singhal,et al.  COPASI - a COmplex PAthway SImulator , 2006, Bioinform..

[25]  Christophe Junot,et al.  Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review. , 2011, Clinical biochemistry.

[26]  Jason A. Papin,et al.  Applications of genome-scale metabolic reconstructions , 2009, Molecular systems biology.

[27]  M. Ghoul,et al.  Production of phenylpropanoid compounds by recombinant microorganisms expressing plant-specific biosynthesis genes , 2008 .

[28]  John R. Haliburton,et al.  Optimization of a heterologous mevalonate pathway through the use of variant HMG-CoA reductases. , 2011, Metabolic engineering.

[29]  P. K. Ajikumar,et al.  The future of metabolic engineering and synthetic biology: towards a systematic practice. , 2012, Metabolic engineering.

[30]  Elizabeth Brunk,et al.  Integrating computational methods to retrofit enzymes to synthetic pathways , 2012, Biotechnology and bioengineering.

[31]  Takumi Akiyama,et al.  Cross‐reaction of chalcone synthase and stilbene synthase overexpressed in Escherichia coli , 1999, FEBS letters.

[32]  Adam M. Feist,et al.  A comprehensive genome-scale reconstruction of Escherichia coli metabolism—2011 , 2011, Molecular systems biology.

[33]  Kim Sneppen,et al.  Pathway identification by network pruning in the metabolic network of Escherichia coli , 2009, Bioinform..

[34]  M. Nei,et al.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. , 2011, Molecular biology and evolution.

[35]  J. Beekwilder,et al.  Production of Resveratrol in Recombinant Microorganisms , 2006, Applied and Environmental Microbiology.

[36]  Keith E. J. Tyo,et al.  Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli , 2010, Science.

[37]  Pablo Carbonell,et al.  Enumerating metabolic pathways for the production of heterologous target chemicals in chassis organisms , 2012, BMC Systems Biology.

[38]  D. G. Gibson,et al.  Enzymatic Assembly of Overlapping DNA Fragments , 2011, Methods in Enzymology.

[39]  Carl Kingsford,et al.  What are decision trees? , 2008, Nature Biotechnology.

[40]  Miguel Rocha,et al.  OptFlux: an open-source software platform for in silico metabolic engineering , 2010, BMC Systems Biology.

[41]  Stefan Schuster,et al.  Systems biology Metatool 5.0: fast and flexible elementary modes analysis , 2006 .

[42]  Ron Wehrens,et al.  The pls Package: Principal Component and Partial Least Squares Regression in R , 2007 .

[43]  B. Tsvetanova,et al.  Genetic assembly tools for synthetic biology. , 2011, Methods in enzymology.

[44]  B. Pfeifer,et al.  Metabolic flux analysis and pharmaceutical production. , 2010, Metabolic engineering.

[45]  Susumu Goto,et al.  KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..

[46]  Yinjie J. Tang,et al.  Separation and mass spectrometry in microbial metabolomics. , 2008, Current opinion in microbiology.

[47]  J. Nielsen,et al.  Opportunities for yeast metabolic engineering: Lessons from synthetic biology , 2011, Biotechnology journal.